Provided by Tiger Trade Technology Pte. Ltd.

Sunshine Biopharma Inc.

0.8998
+0.05876.98%
Post-market: 0.8900-0.0098-1.09%19:31 EDT
Volume:157.77K
Turnover:135.77K
Market Cap:3.49M
PE:-0.09
High:0.8999
Open:0.8200
Low:0.8200
Close:0.8411
52wk High:24.30
52wk Low:0.8200
Shares:3.88M
Float Shares:3.81M
Volume Ratio:1.07
T/O Rate:4.14%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-10.0329
EPS(LYR):-14.3739
ROE:-21.92%
ROA:-9.91%
PB:0.13
PE(LYR):-0.06

Loading ...

Sunshine Biopharma Says Study Shows Mr1-114 Sars-cov-2 Inhibitor Effective in Mice, Potent in Vitro Across Variants

Reuters
·
Jul 20

Sunshine Biopharma Announces Release of Research Findings Press Statement

Reuters
·
Jul 20

Sunshine Biopharma Settles Dispute with Former Nora Pharma President for CAD 1.5 Million

Reuters
·
Jul 11

Sunshine Biopharma Wins Canadian Approval for Generic Arimidex Tablet

Reuters
·
Jun 25

Sunshine Biopharma shareholders OK Nasdaq-related approval provisions for Series C warrants from $6 million offering

Reuters
·
Jun 09

Sunshine Biopharma wins Canadian approval for generic Xarelto drug rivaroxaban tablets

Reuters
·
Jun 01

NASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM

Reuters
·
Jun 01

NASDAQ TRADE HALT HALT NEWS PENDING AT 03:28 AM

Reuters
·
May 30

Sunshine Biopharma Inc trading halted, news pending

TIPRANKS
·
May 30

Sunshine Biopharma shareholder approved discounted share issuance above 20% Nasdaq limit

Reuters
·
May 30

Sunshine Biopharma files draft information statement on warrant approval provisions

Reuters
·
May 30

Sunshine Biopharma wins US patent for coronavirus treatment technology

Reuters
·
May 29

Sunshine Biopharma executes 1-for-10 reverse stock split effective June 1 to maintain Nasdaq listing

Reuters
·
May 28

Sunshine Biopharma wins Canadian approval for generic amoxicillin

Reuters
·
May 21

Sunshine Biopharma prices USD 6 million public offering at USD 0.5 per unit

Reuters
·
May 19

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:31 AM

Reuters
·
May 18

Sunshine Biopharma Q1 FY26 net loss widens to $1.24 million; sales fall 9.1% to $8.09 million

Reuters
·
May 14

Sunshine Biopharma files to sell 5.825M common units

TIPRANKS
·
May 13

Sunshine Biopharma expects to reduce expenses by $2M-$3M in 2026

TIPRANKS
·
Apr 06

Sunshine Biopharma FY25 net loss widens 16.39% to $5.98 million

Reuters
·
Apr 03